Capreomycin sulfate labels and packages: Difference between revisions

Revision as of 00:30, 25 December 2013

Capreomycin Sulfate
CAPASTAT SULFATE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

CAPASTAT® SULFATE Container Label Principal Display Panel Text:^[1]

1 VIAL NDC 17478-080-50

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

Rx only

CAPASTAT® SULFATE Carton Label Principal Display Panel Text:

CAPASTAT® SULFATE

CAPREOMYCIN FOR INJECTION, USP

Equivalent to 1 g Capreomycin Activity

FOR INTRAMUSCULAR AND INTRAVENOUS INFUSION ONLY

Rx only

Adapted from the FDA Package Insert.

@@ Line 23: / Line 23: @@
 {|
 |-
-| [[File:CAPASTAT_SULFATE__CAPREOMYCIN__INJECTION__POWDER__FOR_SOLUTION__AKORN_.jpg|800px|thumb]]
+| [[File:Capreomycin_4.jpg|800px|thumb]]
 |-
 |}